Dong-a Pharmaceutical Co. Ltd. is reportedly planning to acquire M.I.Tech Co., Ltd., according to a report by News1 Korea. The deal is valued at approximately KRW 12 billion reportedly.

PricewaterhouseCoopers LLP has been hired by M.I.Tech as its financial advisor to assist in the sale process.